Zeng, Lishi
91  results:
Search for persons X
?
3

Combination Foretinib and Anti-PD-1 Antibody Immunotherapy ..:

Fu, Yuyin ; Peng, Yujia ; Zhao, Shengyan...
Frontiers in Cell and Developmental Biology.  9 (2021)  - p. , 2021
 
?
5

Drivers and inhibitors of consumer adoption to a new produc..:

Zeng, Lishi (PhD)
https://opus4.kobv.de/opus4-hs-geisenheim/frontdoor/index/index/docId/20.  , 2021
 
?
 
?
8

Combination Foretinib and Anti-PD-1 Antibody Immunotherapy ..:

Yuyin Fu ; Yujia Peng ; Shengyan Zhao...
https://www.frontiersin.org/articles/10.3389/fcell.2021.689727/full.  , 2021
 
?
11

Table_1_Combination Foretinib and Anti-PD-1 Antibody Immuno..:

Yuyin Fu (11096313) ; Yujia Peng (7008695) ; Shengyan Zhao (11096316)...
https://figshare.com/articles/dataset/Table_1_Combination_Foretinib_and_Anti-PD-1_Antibody_Immunotherapy_for_Colorectal_Carcinoma_docx/14931192.  , 2021
 
?
13

Catalytic ability characterization of in situ synthesized P..:

Zhang, Rui ; Zeng, Qiang ; Wang, Min.
Chemical Communications.  60 (2024)  40 - p. 5310-5313 , 2024
 
?
15

Determination of potential thresholds for N-ethyl-N-nitroso..:

Zhu, Xuejiao ; Huo, Jiao ; Zeng, Zhu...
Environmental Science and Pollution Research.  29 (2022)  56 - p. 85128-85142 , 2022
 
1-15